Rebecca Hsu

Ms. Rebecca Hsu

Evans School of Public Policy and Governance, University of Washington
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2020 in Frontiers in Human Neuroscience
Verified
Journal Article
Open access
PDF file
KMKatrina A. Muñoz
Katrina A. Muñoz
KKKristin Kostick
Kristin Kostick
CSClarissa Sanchez
Clarissa Sanchez
LKLavina Kalwani
Lavina Kalwani
LTLaura Torgerson
Laura Torgerson
GLGabriel Lázaro-Muñoz
Gabriel Lázaro-Muñoz
Interest and investment in closed-loop or adaptive deep brain stimulation (aDBS) systems have quickly expanded due to this neurotechnology’s potential to more safely and effectively treat refractory movement and psychiatric disorders compared to conventional DBS. A large neuroethics literature outlines potential ethical concerns about conventional DBS and aDBS systems. Few studies, however, have examined stakeholder perspectives about ethical issues in aDBS research and other next-generation DBS devices. To help fill this gap, we conducted semi-structured interviews with researchers involved in aDBS trials (n = 23) to gain insight into the most pressing ethical questions in aDBS research and any concerns about specific features of aDBS devices, including devices’ ability to measure brain activity, automatically adjust stimulation, and store neural data. Using thematic content analysis, we identified 8 central themes in researcher responses. The need to measure and store neural data for aDBS raised concerns among researchers about data privacy and security issues (noted by 91% of researchers), including the avoidance of unintended or unwanted third-party access to data. Researchers reflected on the risks and safety (83%) of aDBS due to the experimental nature of automatically modulating then observing stimulation effects outside a controlled clinical setting and in relation to need for surgical battery changes. Researchers also stressed the importance of ensuring informed consent and adequate patient understanding (74%). Concerns related to automaticity and device programming (65%) were discussed, including current uncertainties about biomarker validity. Additionally, researchers discussed the potential impacts of automatic stimulation on patients’ autonomy and control over stimulation (57%). Lastly, researchers discussed concerns related to patient selection (defining criteria for candidacy) (39%), challenges of ensuring post-trial access to care and device maintenance (39%), and potential effects on personality and identity (30%). To help address researcher concerns, we discuss the need to minimize cybersecurity vulnerabilities, advance biomarker validity, promote the balance of device control between patients and clinicians, and enhance ongoing informed consent. The findings from this study will help inform policies that will maximize the benefits and minimize potential harms of aDBS and other next-generation DBS devices.

1 May 2024 in Stigma and Health
Verified
Journal Article
Closed access
AGAmanda Gutierrez
Amanda Gutierrez
SSSophie C. Schneider
Sophie C. Schneider
RIRubaiya Islam
Rubaiya Islam
JRJill Robinson
Jill Robinson
RHRebecca Hsu
Rebecca Hsu
CGChristi J. Guerrini
Christi J. Guerrini

1 January 2019 in Journal of Law, Medicine & Ethics
Verified
Journal Article
Open access
PDF file
JBJuli M. Bollinger
Juli M. Bollinger
PZPeter D. Zuk
Peter D. Zuk
MMMary A. Majumder
Mary A. Majumder
EVErika Versalovic
Erika Versalovic
AVAngela G. Villanueva
Angela G. Villanueva
RCRobert Cook-Deegan
Robert Cook-Deegan
A 2011 National Academies of Sciences report called for an “Information Commons” and a “Knowledge Network” to revolutionize biomedical research and clinical care. We interviewed 41 expert stakeholders to examine governance, access, data collection, and privacy in the context of a medical information commons. Stakeholders' attitudes about MICs align with the NAS vision of an Information Commons; however, differences of opinion regarding clinical use and access warrant further research to explore policy and technological solutions.

10 July 2020 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
MMMegan D. Maxwell
Megan D. Maxwell
RHRebecca Hsu
Rebecca Hsu
RIRubaiya Islam
Rubaiya Islam
JRJill O. Robinson
Jill O. Robinson
SPStacey Pereira
Stacey Pereira
MCMauricio De Castro
Mauricio De Castro

Verified
Journal Article
Open access
PDF file
RHRebecca Hsu
Rebecca Hsu
AGAmanda Gutierrez
Amanda Gutierrez
SSSophie K. Schellhammer
Sophie K. Schellhammer
JRJill Robinson
Jill Robinson
SSSarah Scollon
Sarah Scollon
AMAmy Mcguire
Amy Mcguire
Pediatric oncologists’ perspectives around returning and incorporating tumor and germline genomic sequencing (GS) results into cancer care are not well-described. To inform optimization of cancer genomics communication, we assessed oncologists’ experiences with return of genomic results (ROR), including their preparation/readiness for ROR, collaboration with genetic counselors (GCs) during ROR, and perceived challenges. The BASIC3 study paired pediatric oncologists with GCs to return results to patients’ families. We thematically analyzed 24 interviews with 12 oncologists at two post-ROR time points. Oncologists found pre-ROR meetings with GCs and geneticists essential to interpreting patients’ reports and communicating results to families. Most oncologists took a collaborative ROR approach where they discussed tumor findings and GCs discussed germline findings. Oncologists perceived many roles for GCs during ROR, including answering families’ questions and describing information in lay language. Challenges identified included conveying uncertain information in accessible language, limits of oncologists’ genetics expertise, and navigating families’ emotional responses. Oncologists emphasized how GCs’ and geneticists’ support was essential to ROR, especially for germline findings. GS can be successfully integrated into cancer care, but to account for the GC shortage, alternative ROR models and access to genetics resources will be needed to better support families and avoid burdening oncologists.

2 January 2023 in Journal of Adolescent and Young Adult Oncology
Verified
Journal Article
Closed access
AGAmanda Gutierrez
Amanda Gutierrez
JRJill O. Robinson
Jill O. Robinson
RRRobin Raesz-Martinez
Robin Raesz-Martinez
ICIsabel Canfield
Isabel Canfield
MMMary A. Majumder
Mary A. Majumder
JMJanet Malek
Janet Malek
Purpose: With increased use of genomic testing in cancer research and clinical care, it is important to understand the perspectives and decision-making preferences of adolescents and young adults (AYAs) with cancer and their treating oncologists. Methods: We conducted an interview substudy of the BASIC3 Study, which enrolled newly diagnosed cancer patients <18 years of age with assent. Of 32 young adults (YAs) with cancer who reached the age of majority (AOM; 18 years) while on study, 12 were successfully approached and all consented to study continuation at AOM. Of those, seven completed an interview. Patients' oncologists, who enrolled and participated in return of clinical genomic results, were also interviewed ( n = 12). Interviews were transcribed, deidentified, and analyzed using thematic analysis. Results: YAs cited the possibility of helping others and advancing science as major reasons for their assent to initial study enrollment and their willingness to consent at AOM. YAs thought obtaining informed consent from research participants for study continuation at AOM was a good idea in case they changed their minds or wanted to make their own decisions, and to keep them aware of study activities. There was diversity in what YAs understood and learned from genomic testing: some recalled specific findings, while some remembered minimal information about their results. Oncologists varied in their assessment of adolescents' engagement with the study and understanding of their results. Conclusion: Given the different ways AYAs engage with genomic information, careful assessment of AYAs' diverse communication and decision-making preferences is needed to tailor interactions accordingly.